Literature DB >> 31367546

Hepatic iron overload identified by magnetic resonance imaging-based T2* is a predictor of non-diagnostic elastography.

Hassan M Ghoz1, Paul T Kröner1, Fernando F Stancampiano2, Andrew W Bowman3, Prakash Vishnu4, Michael G Heckman5, Nancy N Diehl5, Ethan McLeod6, Naveed Nikpour6, William C Palmer1.   

Abstract

BACKGROUND: Magnetic resonance elastography (MRE) is a non-invasive test used to assess liver stiffness and fibrosis in chronic liver disease, which includes systemic iron overload. However, iron deposition by itself is associated with technical failure of MRE of the liver which necessitates the use of invasive liver biopsy as an alternative monitoring method for these patients. T2*-weighted magnetic resonance imaging (T2*) is a reliable modality to asses for hepatic as well as total body iron overload. Therefore, we aimed to determine a cutoff value on the T2* reading at which MRE would no longer provide accurate stiffness measurements in patients with iron overload.
METHODS: Ninety-five patients with iron overload who underwent MRE at our institution, between 2010 and 2017 were reviewed retrospectively. We compared T2* values between patients with adequate elastography (N=63) versus those with non-diagnostic elastography (N=32). We additionally examined the ability of T2* to predict the likelihood of non-diagnostic elastography by estimating area under the ROC curve (AUC).
RESULTS: T2* was significantly different between patients with and without an adequate elastography (P<0.0001) and predicted occurrence of non-diagnostic elastography with an AUC of 0.95. All patients with a non-diagnostic elastography had a T2* value below 20 milliseconds (ms), and correspondingly 55% of the patients with a T2* value below 20 ms had a non-diagnostic elastography. The subgroups of patients with a T2* value ≤10, ≤8, and ≤6 ms, had a higher likelihood of non-diagnostic elastography (87%, 92%, and 95%, respectively).
CONCLUSIONS: T2* can be used to accurately predict which patients are most likely to have a non-diagnostic elastography reading. T2* of 20 ms or lower reflects a higher likelihood of non-diagnostic elastography.

Entities:  

Keywords:  Hemochromatosis; T2* cut-off value; magnetic resonance elastography (MRE)

Year:  2019        PMID: 31367546      PMCID: PMC6629566          DOI: 10.21037/qims.2019.05.13

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  29 in total

1.  Hepatic iron concentration and total body iron stores in thalassemia major.

Authors:  E Angelucci; G M Brittenham; C E McLaren; M Ripalti; D Baronciani; C Giardini; M Galimberti; P Polchi; G Lucarelli
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

2.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.

Authors:  L J Anderson; S Holden; B Davis; E Prescott; C C Charrier; N H Bunce; D N Firmin; B Wonke; J Porter; J M Walker; D J Pennell
Journal:  Eur Heart J       Date:  2001-12       Impact factor: 29.983

3.  Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance.

Authors:  Timothy G St Pierre; Paul R Clark; Wanida Chua-anusorn; Adam J Fleming; Gary P Jeffrey; John K Olynyk; Pensri Pootrakul; Erin Robins; Robert Lindeman
Journal:  Blood       Date:  2004-07-15       Impact factor: 22.113

4.  MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients.

Authors:  John C Wood; Cathleen Enriquez; Nilesh Ghugre; J Michael Tyzka; Susan Carson; Marvin D Nelson; Thomas D Coates
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

5.  R2* imaging of transfusional iron burden at 3T and comparison with 1.5T.

Authors:  Pippa Storey; Alexis A Thompson; Christine L Carqueville; John C Wood; R Andrew de Freitas; Cynthia K Rigsby
Journal:  J Magn Reson Imaging       Date:  2007-03       Impact factor: 4.813

6.  Liver biopsy:complications and risk factors.

Authors:  Pornpen Thampanitchawong; Teerha Piratvisuth
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

7.  Incidence of liver disease in people with HFE mutations.

Authors:  G Willis; J Z Wimperis; R Lonsdale; I W Fellows; M A Watson; L M Skipper; B A Jennings
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

Review 8.  Iron, hemochromatosis, and hepatocellular carcinoma.

Authors:  Kris V Kowdley
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

9.  Prognostic factors and survival in patients with hereditary hemochromatosis and cirrhosis.

Authors:  Melanie D Beaton; Paul C Adams
Journal:  Can J Gastroenterol       Date:  2006-04       Impact factor: 3.522

10.  Idiopathic hemochromatosis, an iron storage disease. A. Iron metabolism in hemochromatosis.

Authors:  S C FINCH; C A FINCH
Journal:  Medicine (Baltimore)       Date:  1955-12       Impact factor: 1.889

View more
  7 in total

1.  Imaging biomarkers of diffuse liver disease: current status.

Authors:  Bachir Taouli; Filipe Caseiro Alves
Journal:  Abdom Radiol (NY)       Date:  2020-06-25

2.  Collagen deposition in the liver is strongly and positively associated with T1rho elongation while fat deposition is associated with T1rho shortening: an experimental study of methionine and choline-deficient (MCD) diet rat model.

Authors:  Feng Zhao; Nan Zhou; Ji-Li Wang; Hua Zhou; Li-Qiu Zou; Wei-Xiang Zhong; Jian He; Cun-Jing Zheng; Sen-Xiang Yan; Yì Xiáng J Wáng
Journal:  Quant Imaging Med Surg       Date:  2020-12

Review 3.  Magnetic resonance elastography of the liver: everything you need to know to get started.

Authors:  Kay M Pepin; Christopher L Welle; Flavius F Guglielmo; Jonathan R Dillman; Sudhakar K Venkatesh
Journal:  Abdom Radiol (NY)       Date:  2021-11-01

4.  Preliminary experience with 3T magnetic resonance elastography imaging of the liver.

Authors:  Anagha Joshi; Mridula M Muthe; Vikrant Firke; Harshal Badgujar
Journal:  SA J Radiol       Date:  2021-05-12

Review 5.  Diagnosis and Management of Genetic Iron Overload Disorders.

Authors:  William C Palmer; Prakash Vishnu; William Sanchez; Bashar Aqel; Doug Riegert-Johnson; Leigh Ann Kenda Seaman; Andrew W Bowman; Candido E Rivera
Journal:  J Gen Intern Med       Date:  2018-09-17       Impact factor: 6.473

6.  Abdominal magnetic resonance imaging examination of Tibetan patients with abnormal iron metabolism and a preliminary study of correlations with blood cell analysis.

Authors:  Yi Zhou; Jin-Li Meng; Li Feng; Yong-Hong Huang; Jin Ye; Man Li; Zhong-You Xu; Xiang-Wei Li; Fang Yuan; Bin Song
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

Review 7.  Multiparametric MR mapping in clinical decision-making for diffuse liver disease.

Authors:  Helena B Thomaides-Brears; Rita Lepe; Rajarshi Banerjee; Carlos Duncker
Journal:  Abdom Radiol (NY)       Date:  2020-08-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.